Agios Pharmaceuticals (AGIO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to -$854.4 million.
- Agios Pharmaceuticals' Enterprise Value rose 439.57% to -$854.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$854.4 million, marking a year-over-year increase of 439.57%. This contributed to the annual value of -$854.4 million for FY2025, which is 439.57% up from last year.
- Per Agios Pharmaceuticals' latest filing, its Enterprise Value stood at -$854.4 million for Q4 2025, which was up 439.57% from -$952.9 million recorded in Q3 2025.
- Over the past 5 years, Agios Pharmaceuticals' Enterprise Value peaked at -$569.9 million during Q2 2024, and registered a low of -$2.3 billion during Q1 2021.
- Its 5-year average for Enterprise Value is -$956.0 million, with a median of -$873.9 million in 2025.
- Per our database at Business Quant, Agios Pharmaceuticals' Enterprise Value tumbled by 34182.94% in 2021 and then skyrocketed by 6045.86% in 2022.
- Over the past 5 years, Agios Pharmaceuticals' Enterprise Value (Quarter) stood at -$1.0 billion in 2021, then rose by 23.22% to -$783.1 million in 2022, then increased by 0.79% to -$776.9 million in 2023, then decreased by 15.03% to -$893.7 million in 2024, then increased by 4.4% to -$854.4 million in 2025.
- Its Enterprise Value stands at -$854.4 million for Q4 2025, versus -$952.9 million for Q3 2025 and -$938.9 million for Q2 2025.